Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs
Main Authors: | Bang, Gilles, Prieur, Eric, Roussilhon, Christian, Druilhe, Pierre |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228738/ |
Similar Items
-
A Malaria Vaccine That Elicits in Humans Antibodies Able to Kill Plasmodium
falciparum
by: Druilhe, Pierre, et al.
Published: (2005) -
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
by: McCarthy, James S., et al.
Published: (2011) -
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months
by: Lusingu, John PA, et al.
Published: (2009) -
Using Multivalent Adenoviral Vectors for HIV Vaccination
by: Gu, Linlin, et al.
Published: (2013) -
Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children
by: Withers, Mark R, et al.
Published: (2006)